New research has discovered a unique and promising avenue for diagnosing Alzheimer’s disease (AD) earlier – by analysing AD biomarkers in blood – so that the impacts of dementia can be reduced.
Fasting’s potential in fighting cognitive decline needs more human trials
Despite promising animal studies on fasting and caloric restrictions for neurodegenerative diseases, human clinical trials are scarce, underscoring the need for more research to validate